RESUMEN
To the best of our knowledge, the German Association for the Control of Viral Diseases (DVV) e.V. and the Society for Virology (GfV) e.V. are the first in Europe to provide precise recommendations for the management of health care workers (HCWs) who are infected with human immunodeficiency virus (HIV). Requirements for HIV-infected HCWs need to be clearly defined. With a permanent viral burden of less than or equal to 50 copies/mL, HIV-positive HCWs are allowed to perform any surgery and any invasive procedure, as long as the infected HCW uses double-gloving, undergoes follow-up routinely by occupational medicine professionals, undergoes a quarterly examination of viral burden, and has a regular medical examination by a physician who has expertise in the management of HIV. Unrestricted professional activity is only possible with a strict compliance to take antiretroviral therapy and if the HIV-infected HCW strictly adheres to the recommended infection control procedures. Complete compliance with the recommendation almost certainly leads to no HIV transmission risk in patient care.
Asunto(s)
Infección Hospitalaria/prevención & control , Seropositividad para VIH/transmisión , Transmisión de Enfermedad Infecciosa de Profesional a Paciente/prevención & control , Fármacos Anti-VIH/administración & dosificación , Infección Hospitalaria/transmisión , Alemania , Guantes Quirúrgicos/estadística & datos numéricos , Adhesión a Directriz/legislación & jurisprudencia , Humanos , Lesiones por Pinchazo de Aguja/virología , Factores de Riesgo , Revisión de Utilización de Recursos , Carga ViralRESUMEN
Sorangicin A, a macrolide polyether antibiotic and the ansamycin antibiotic rifampicin inhibit DNA-dependent RNA polymerase to a similar extent. Resistance to sorangicin A is due to a mutation in the RNA polymerase which renders the enzyme less sensitive. Parallel investigations with rifampicin revealed partial cross-resistance, which was more marked in sorangicin A-resistant mutants than in rifampicin-resistant mutants.